Harvest Investment Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Harvest Investment Services's MRNA Position: Q1 2022 in Review
Harvest Investment Services sold out of Moderna (MRNA) in Q1 2022, closing a stake of 807 shares — an estimated $205K sold.
Harvest Investment Services first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $2.42M in Q4 2020. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.
- Harvest Investment Services reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
- Harvest Investment Services sold 807 Moderna shares in Q1 2022, an estimated $205K.
- Harvest Investment Services first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
- Harvest Investment Services's Moderna position peaked at $2.42M in Q4 2020.
- 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.
Based on Harvest Investment Services's 13F filing for Q1 2022, filed 3 May 2022.